Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Eisai CO Ltd ADR (OP: ESALY)
51.54 USD  +0.18 (+0.35%)
Official Closing Price  /  Updated: 3:58 PM EDT, Aug 21, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 4,100
Open 51.89
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 51.36
Today's Range 51.54 - 51.89
52wk Range 49.89 - 101.80
Shares Outstanding 286,338,549
Dividend Yield N/A
Performance
YTD
-33.50%
-33.50%
1 Month
-5.26%
-5.26%
3 Month
-12.14%
-12.14%
6 Month
-36.07%
-36.07%
1 Year
-42.02%
-42.02%
Top News
More News
Eisai to Refresh and Launch Sahne Cream After 20 Years with Mild Scent and New Package
from ACN Newswire
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Breakthrough Therapy Designation from FDA
from ACN Newswire
More News
Read More
Eisai Presented Latest Trends of Treatment for Alzheimer's at AAIC 2019
from ACN Newswire
Eisai Presented Data Showing Quantification of Tau Microtubule Binding Region at AAIC 2019
from ACN Newswire
Eisai Presents Research Evaluating Correlation of Highly-Precisely Measured Amyloid Beta in Plasma and Cerebrospinal Fluid with Newly Developed Automated Protein Assay System at AAIC 2019
from ACN Newswire
Eisai Presents Nonclinical Research Results of Elenbecestat at AAIC 2019
from ACN Newswire
Eisai's Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer in China
from ACN Newswire
Eisai Listed for 18th Consecutive Year in FTSE4Good Index Series
from ACN Newswire
Latest Data on Eisai's Alzheimer's Disease/ Dementia Pipeline to be Presented at AAIC 2019
from ACN Newswire
Eisai Center for Genetics Guided Dementia Discovery Commences Full-Scale Operation Toward Innovative Dementia Treatments With New Drug Discovery Approach in Cambridge, Massachusetts
from ACN Newswire
Eisai Enters Into Collaboration Research Agreement With University of Dundee on Targeted Protein Degradation Toward Cancer Drug Discovery
from ACN Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.